BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 3549904)

  • 1. Expression of hemopoietic histocompatibility antigens on H-2-loss variants of F1 hybrid lymphoma cells: evidence consistent with trans gene regulation.
    Rembecki RM; Bennett M; Kumar V; Potter TA
    J Immunol; 1987 Apr; 138(8):2734-8. PubMed ID: 3549904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ability of H-2Dd molecule to affect natural resistance to hemopoietic allografts is an intrinsic property shared by Ddm1 but not Ld.
    Milisauskas VK; Nakamura I
    Eur J Immunol; 1994 Feb; 24(2):336-42. PubMed ID: 8299682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The nature of hemopoietic histocompatibility determinants. Differential sensitivity of Hh-1b and H-2b determinants to tunicamycin.
    Milisauskas VK; Nakamura I
    J Immunol; 1988 Aug; 141(4):1246-51. PubMed ID: 2456347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allospecificities of B6D2F1 hybrid NK cell subsets defined by Ly-49A expression.
    Basiri H; Kiura K; DeNardin EG; Nakamura I
    J Immunol; 1995 Sep; 155(6):2822-32. PubMed ID: 7673698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rejection of bone marrow cell allografts by natural killer cell subsets: 5E6+ cell specificity for Hh-1 determinant 2 shared by H-2d and H-2f.
    Sentman CL; Kumar V; Bennett M
    Eur J Immunol; 1991 Nov; 21(11):2821-8. PubMed ID: 1718761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Class I H-2Db determinants are not involved in hybrid resistance to parental H-2b/Hh-1b bone marrow allograft.
    Milisauskas VK; Kaminsky SG; Nakamura I
    Eur J Immunol; 1987 Jul; 17(7):1043-9. PubMed ID: 2440692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific inhibition of hybrid resistance in F1 hybrid mice pretreated with parent-strain spleen cells. II. Evidence for an Hh-1 antigen-specific tolerization.
    Kosmatopoulos K; Scott-Algara D; Halle-Pannenko O
    J Immunol; 1988 Nov; 141(10):3285-92. PubMed ID: 2460528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow cell transplants involving intra-H-2 recombinant inbred mouse strains. Evidence that hemopoietic histocompatibility-1 (Hh-1) genes are distinct from H-2D or H-2L.
    Rembecki RM; Kumar V; David CS; Bennett M
    J Immunol; 1988 Oct; 141(7):2253-60. PubMed ID: 3049802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphism of Hh-1, the mouse hemopoietic histocompatibility locus.
    Rembecki RM; Kumar V; David CS; Bennett M
    Immunogenetics; 1988; 28(3):158-70. PubMed ID: 2457549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
    Green WR
    J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemopoietic histocompatibility (Hh-1) regulatory and structural genes of the f haplotype map to H-2.
    Rembecki RM; Kumar V; David CS; Bennett M
    Transplantation; 1990 Mar; 49(3):633-8. PubMed ID: 2316021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leucyl-leucine methyl ester treatment of donor cells permits establishment of immunocompetent parent----F1 chimeras that are selectively tolerant of host alloantigens.
    Thiele DL; Calomeni JA; Lipsky PE
    J Immunol; 1987 Oct; 139(7):2137-42. PubMed ID: 3309052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of genetic resistance to marrow grafts in mice by interferon-alpha/beta.
    Afifi MS; Kumar V; Bennett M
    J Immunol; 1985 Jun; 134(6):3739-45. PubMed ID: 2985694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of the K and I regions of the H-2 complex in resistance to hemopoietic allografts.
    Drizlikh G; Schmidt-Sole J; Yankelevich B
    J Exp Med; 1984 Apr; 159(4):1070-82. PubMed ID: 6142918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abrogation of hybrid resistance to bone marrow engraftment by graft-vs-host-induced immune deficiency.
    Hakim FT; Shearer GM
    J Immunol; 1986 Nov; 137(10):3109-16. PubMed ID: 3095424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of newborn liver cells as a murine model for cord blood cell transplantation.
    Davenport C; Kumar V; Bennett M
    J Immunol; 1993 Aug; 151(3):1597-605. PubMed ID: 8101544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular loss variants of the murine major histocompatibility complex: nonexpression of H-2K antigens associated with marked reduction in H-2K mRNA as determined by oligonucleotide hybridization analysis.
    Zeff RA; Geier SS; Nathenson SG
    J Immunol; 1986 Aug; 137(4):1366-70. PubMed ID: 3734458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex and H-2 haplotype control the resistance of CBA-BALB hybrids to the induction of T cell lymphoma by Moloney leukemia virus.
    Storch TG; Chused TM
    J Immunol; 1984 Nov; 133(5):2797-800. PubMed ID: 6332861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AKR/J gene(s) unlinked to H-2 determines dominant inheritance of lymphocyte hyporesponsiveness to acetylcholine receptor.
    Gorzynski TJ; Lennon VA; Nathanson RM; David CS
    J Immunol; 1985 Apr; 134(4):2079-83. PubMed ID: 3919088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hybrid and allogeneic resistance to T cell grafts mediated by murine NK and CD8+ T cells.
    Davenport C; Haile A; Kumar V; Bennett M
    J Immunol; 1995 Mar; 154(6):2568-77. PubMed ID: 7876533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.